St Louis, MONCT06823089Now EnrollingIRB Ready

Osteoarthritis, Hip Clinical Trial in St Louis, MO

Access cutting-edge osteoarthritis, hip treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.

Sponsored by Cytex Therapeutics, Inc.

Quick Self-Assessment

See if you qualify for this St Louis location

Preparing your pre-screening questions…

Expert Care in St Louis

Access osteoarthritis, hip specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related osteoarthritis, hip treatment provided free

Apply for This St Louis Location

Check if you qualify for this osteoarthritis, hip clinical trial in St Louis, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to St Louis

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit St Louis site if eligible
  4. 4Begin participation

About This Osteoarthritis, Hip Study in St Louis

Any patient aged 14 or older up to 64 years of age with hip disease, resulting in loss of articular cartilage integrity on the femoral head (e.g., femoroacetabular impingement or other structural deformity), has failed conservative care, and is a candidate for surgical intervention to treat.

Sponsor: Cytex Therapeutics, Inc.

Who Can Participate

Inclusion Criteria

At least 14 years of age to no older than 64 years of age Subjects 14-21 years of age must have radiographic evidence of epiphyseal closure in the hip joint
Failed at least 6 weeks of conservative treatment (e.g., anti-inflammatory pain medications, physical therapy, injections)
Duration of symptoms consistent with intra-articular disease (i.e., groin, lateral and/or posterior hip pain) that have persisted for at least 3 months)
Loss of articular cartilage integrity (\~1 - 6 cm\^2 in area) on the femoral head (confirmed by MRI), without an opposing lesion, that can be treated with a single ReNew Hip Implant
Radiographic assessment with joint space width \> 2 mm (verified by x-ray)
Meets an acceptable preoperative medical clearance and is free of conditions that would pose excessive operative risk, in the opinion of the investigator
Given consent to participate in the study
Able to understand the purpose of the study, his/her role, and is available for follow-up for the duration of the study:
Subject has signed an IRB (Institutional Review Board) approved Informed Consent Form agreeing to participate in the extension study after the nature, scope, and possible consequences of the study have been explained in an understandable form
Subject is able to fully understand the purpose of the study, his/her role as a participant in the study, and plans to be available through five years post-operative follow-up

Exclusion Criteria

Current users of nicotine in any form (e.g., cigarettes, e- cigarettes/vaping, chewing tobacco, nicotine patches, gum, lozenges), or individuals who have discontinued nicotine use less than 30 days prior to screening.
Type 1 or Type 2 Diabetes
Systemic steroid use in the 3 months prior to screening
Coxa plana, coxa magna, or proximal femoral focal deficiency on the femoral head that would result in implant mismatch of the femoral head contour
Any acute or chronic condition that would limit the ability of the patient to participate in the study (e.g., COPD, congestive heart failure),
Bleeding disorders
Current cancer (with the exception of non-melanoma skin cancer)
Pregnancy or planning to become pregnant during the study period
Active infection or sepsis
History of local hip infection
Known metastatic or neoplastic disease
Conditions that may interfere with implant survival or outcomes (e.g., severe dysplasia)
Life expectancy less than 2 years
Intra-articular therapy within 3 months of enrollment
Inadequate bone stock (as determined by SCORE or MORES assessment) to support the device
Femoral head is:
outside of the 46 - 56 mm range in either anteroposterior diameter or lateral diameters or
an aspherical head deformity that results in contour mismatch of 16a
Moderate to severe renal insufficiency
Emotional or neurological condition that would preempt ability or willingness to participate in the study
Above the knee amputation of the contralateral or ipsilateral leg
Known allergies to the components of the device (polycaprolactone)
Is a prisoner

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in St Louis?

Yes, this clinical trial (NCT06823089) has an active research site in St Louis, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Osteoarthritis, Hip Treatment Options in St Louis, MO

If you're searching for osteoarthritis, hip treatment options in St Louis, MO, this clinical trial (NCT06823089) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced osteoarthritis, hip specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all osteoarthritis, hip clinical trials near you to find additional studies recruiting in your area.

More Osteoarthritis Trials in St Louis, MO

See all osteoarthritis clinical trials recruiting in St Louis — not just this study.

Browse Osteoarthritis Trials in St Louis →

Browse More Trials by Condition

Osteoarthritis TrialsAll Conditions →

Ready to Join in St Louis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · St Louis, MO